Ascent Pharmaceuticals, Inc.
Ascent Pharmaceuticals, Inc. (United States) has no DMF, CEP or site registration linked in our records. 7 FDA enforcement records are linked to it.
Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records
Cite as: PharmaTek, “Ascent Pharmaceuticals, Inc.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/ascent-pharmaceuticals-inc
Overview
Ascent Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Central Islip, United States.
FDA compliance signals
7 FDA enforcement records linked to this company.
- 4832022-09-15
Failure to comply with REMS Implementation System
- recall — Class II2021-12-15
Product Mix-up
- recall — Class II2020-11-25
Presence of Foreign Tablet/Capsule: One bottle of Hydrocodone Bitartrate and Acetaminophen Tablets USP 10mg/325 mg contains one Losartan Potassium Tablets, USP 100 mg.
- recall — Class III2018-02-07
Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol
- 4832012-12-06
Following/documenting laboratory controls
- 4832012-12-06
Washing and toilet facilities are deficient
- 4832012-12-06
Samples (various types) representative, identified properly
Is this Ascent Pharmaceuticals, Inc.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.